Nov 21,23
Breaking Barriers: The Success of the COVID-19 Therapeutics Program In the ongoing battle against the COVID-19 pandemic, innovative approaches have proven to be essential in ensuring timely access to life-saving treatments. One remarkable example of such innovation is the COVID-19 Therapeutics Program launched by the Department of Public Health. In collaboration with Health Services Health V Incorporated, Kaisar Permnante, Mercy Read More
Oct 27,23
Low Dose Naltrexone (LDN) for Hashimoto’s and Graves’ Diseases IntroductionAutoimmune thyroid conditions, such as Hashimoto's Thyroiditis and Graves' Disease, can have a significant impact on individuals' lives. Low Dose Naltrexone (LDN) is a medication that has been explored as a potential treatment for these disorders. LDN was originally developed to treat opioid addiction at much higher doses, but its potential Read More